Israel Biotech Fund I, L.p. - Net Worth and Insider Trading
Israel Biotech Fund I, L.p. Net Worth
The estimated net worth of Israel Biotech Fund I, L.p. is at least $89,508 dollars as of 2024-12-28. Israel Biotech Fund I, L.p. is the 10% Owner of Ayala Pharmaceuticals Inc and owns about 3,315,119 shares of Ayala Pharmaceuticals Inc (ADXS) stock worth over $89,508. Details can be seen in Israel Biotech Fund I, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Israel Biotech Fund I, L.p. has not made any transactions after 2020-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Israel Biotech Fund I, L.p.
Israel Biotech Fund I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Israel Biotech Fund I, L.p. owns 2 companies in total, including Ayala Pharmaceuticals Inc (ADXS) , and Advaxis Inc (ADXS) .
Click here to see the complete history of Israel Biotech Fund I, L.p.’s form 4 insider trades.
Insider Ownership Summary of Israel Biotech Fund I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-12 | 10 percent owner |
| ADXS | Advaxis Inc | 2023-01-19 | 10 percent owner |
Israel Biotech Fund I, L.p. Latest Holdings Summary
Israel Biotech Fund I, L.p. currently owns a total of 1 stock. Israel Biotech Fund I, L.p. owns 3,315,119 shares of Ayala Pharmaceuticals Inc (ADXS) as of May 12, 2020, with a value of $89,508.
Latest Holdings of Israel Biotech Fund I, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-12 | 3,315,119 | 0.03 | 89,508 |
Holding Weightings of Israel Biotech Fund I, L.p.
Israel Biotech Fund I, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Israel Biotech Fund I, L.p. has made a total of 1 transactions in Ayala Pharmaceuticals Inc (ADXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ayala Pharmaceuticals Inc is the acquisition of 225,000 shares on May 12, 2020, which cost Israel Biotech Fund I, L.p. around $3 Million.
Insider Trading History of Israel Biotech Fund I, L.p.
- 1
Israel Biotech Fund I, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Israel Biotech Fund I, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Israel Biotech Fund I, L.p. is -20.07%. GuruFocus also compares Israel Biotech Fund I, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Israel Biotech Fund I, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Israel Biotech Fund I, L.p.'s insider trading performs compared to the benchmark.
Performance of Israel Biotech Fund I, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.8 | | | | | |
| Relative Return to S&P 500(%) | -12.76 | | | | | |
Israel Biotech Fund I, L.p. Ownership Network
Israel Biotech Fund I, L.p. Owned Company Details
What does Ayala Pharmaceuticals Inc do?
Who are the key executives at Ayala Pharmaceuticals Inc?
Israel Biotech Fund I, L.p. is the 10 percent owner of Ayala Pharmaceuticals Inc. Other key executives at Ayala Pharmaceuticals Inc include other: shareholder of 10% holder Yair Chaim Schindel , director & CEO Roni Mamluk , and Chief Medical Officer Gary B. Gordon .
Ayala Pharmaceuticals Inc (ADXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ayala Pharmaceuticals Inc (ADXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ayala Pharmaceuticals Inc (ADXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ayala Pharmaceuticals Inc (ADXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ayala Pharmaceuticals Inc Insider Transactions
Israel Biotech Fund I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Israel Biotech Fund I, L.p.. You might contact Israel Biotech Fund I, L.p. via mailing address: 4 Oppenheimer St., Rehovot L3 7670104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
